- Home
- Publications
- Publication Search
- Publication Details
Title
InhibitingMycobacterium tuberculosiswithin and without
Authors
Keywords
-
Journal
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Volume 371, Issue 1707, Pages 20150506
Publisher
The Royal Society
Online
2016-09-27
DOI
10.1098/rstb.2015.0506
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015
- (2016) Frank P. Mockenhaupt et al. Eurosurveillance
- DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization
- (2015) Miroslav Brecik et al. ACS Chemical Biology
- The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence
- (2015) Benjamin K. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase
- (2015) Sudhir Landge et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Whole cell screen based identification of spiropiperidines with potent antitubercular properties
- (2015) Subramanyam J. Tantry et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1
- (2015) Ruth Wassermann et al. Cell Host & Microbe
- Towards host-directed therapies for tuberculosis
- (2015) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Antiinfectives targeting enzymes and the proton motive force
- (2015) Xinxin Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection
- (2015) Roxane Simeone et al. TUBERCULOSIS
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
- (2015) Jan Rybniker et al. Nature Communications
- Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo
- (2015) Roxane Simeone et al. PLoS Pathogens
- Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment
- (2015) Brian C. VanderVen et al. PLoS Pathogens
- 2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
- (2014) João Neres et al. ACS Chemical Biology
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
- (2014) Monalisa Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis
- (2014) Kriti Arora et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
- (2014) Jan Rybniker et al. Cell Host & Microbe
- The Polyketide Synthase Pks13 Catalyzes a Novel Mechanism of Lipid Transfer in Mycobacteria
- (2014) Sabine Gavalda et al. CHEMISTRY & BIOLOGY
- DprE1 - from the Discovery to the Promising Tuberculosis Drug Target
- (2014) Katarina Miku.sova et al. CURRENT PHARMACEUTICAL DESIGN
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Tuberculosis drug discovery in the post-post-genomic era
- (2014) Benoit Lechartier et al. EMBO Molecular Medicine
- Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
- (2014) Manoranjan Panda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
- (2014) Kai Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway inMycobacterium tuberculosisusing conditional mutants
- (2014) Gaëlle S. Kolly et al. MOLECULAR MICROBIOLOGY
- Shortening Treatment for Tuberculosis — Back to Basics
- (2014) Digby F. Warner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
- (2014) Corinne S. Merle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
- (2014) Amina Jindani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Who will develop new antibacterial agents?
- (2014) S. T. Cole PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Mycobacterium tuberculosis Proteins Involved in Mycolic Acid Synthesis and Transport Localize Dynamically to the Old Growing Pole and Septum
- (2014) Clément Carel et al. PLoS One
- Subpolar addition of new cell wall is directed by DivIVA in mycobacteria
- (2014) X. Meniche et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Take five — Type VII secretion systems of Mycobacteria
- (2013) Edith N.G. Houben et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
- (2013) Regina Wilson et al. Nature Chemical Biology
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
- (2013) Thomas R. Ioerger et al. PLoS One
- Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
- (2013) Robert C. Goldman TUBERCULOSIS
- Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis
- (2013) Garrett C. Moraski et al. ACS Medicinal Chemistry Letters
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- MprAB Regulates the espA Operon in Mycobacterium tuberculosis and Modulates ESX-1 Function and Host Cytokine Response
- (2012) X. Pang et al. JOURNAL OF BACTERIOLOGY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Recover the lost art of drug discovery
- (2012) Kim Lewis NATURE
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
- (2012) Roxane Simeone et al. PLoS Pathogens
- MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
- (2011) Valentina La Rosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles
- (2011) Abhijit Datta Khoje et al. BIOORGANIC & MEDICINAL CHEMISTRY
- High-content screening in infectious diseases
- (2011) Priscille Brodin et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery
- (2010) Thierry Christophe et al. Future Medicinal Chemistry
- Leads for antitubercular compounds from kinase inhibitor library screens
- (2010) Sophie Magnet et al. TUBERCULOSIS
- ESX/type VII secretion systems and their role in host–pathogen interaction
- (2009) Roxane Simeone et al. CURRENT OPINION IN MICROBIOLOGY
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Antituberculosis activity of the molecular libraries screening center network library
- (2009) Joseph A. Maddry et al. TUBERCULOSIS
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
- (2009) Subramaniam Ananthan et al. TUBERCULOSIS
- High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
- (2009) Thierry Christophe et al. PLoS Pathogens
- Systematic Genetic Nomenclature for Type VII Secretion Systems
- (2009) Wilbert Bitter et al. PLoS Pathogens
- PhoP: A Missing Piece in the Intricate Puzzle of Mycobacterium tuberculosis Virulence
- (2008) Jesús Gonzalo-Asensio et al. PLoS One
- Control of M. tuberculosis ESAT-6 Secretion and Specific T Cell Recognition by PhoP
- (2008) Wafa Frigui et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now